Search Results - "NESSPOR, T"

CNTO 530 : Molecular pharmacology in human UT-7EPO cells and pharmacokinetics and pharmacodynamics in mice by BUGELSKI, P. J, CAPOCASALE, R. J, VOLK, A, NESSPOR, T, JAMES, I. E, HUANG, C, MAKROPOULOS, D, MARSHALL, D, FISHER, P. W, LU, J, ACHUTHANANDAM, R, SPINKA-DOMS, T, KWOK, D, GRADEN, D

“…CNTO 530 is a 58 kD antibody Fc domain fusion protein, created using Centocor's MIMETIBODY platform, that contains two EMP1 sequences as a pharmacophore. CNTO…”
Get full text

144 (PB132): JNJ-79032421 is a novel membrane restricted mesothelin targeting Tcell engaging bispecific antibody for treatment of mesothelin-positive cancers by Smans, K., Nesspor, T., De Breuker, S., Van Heerde, E., Valckx, A., Van Slycken, N., Sproesser, K., Mattson, B., Packman, K., Fisher, J., Mazzanti, N., Petley, T., Chan, W., Del Rosario, B., Tun, L., Lorenzi, M., Moores, S., Clawson, J., Laquerre, S.

Get full text

CNTO 530: Molecular pharmacology in human UT-7 sub(E) sub(P) sub(O) cells and pharmacokinetics and pharmacodynamics in mice by Bugelski, P J, Capocasale, R J, Makropoulos, D, Marshall, D, Fisher, P W, Lu, J, Achuthanandam, R, Spinka-Doms, T, Kwok, D, Graden, D, Volk, A, Nesspor, T, James, I E, Huang, C

“…CNTO 530 is a 58kD antibody Fc domain fusion protein, created using Centocor's MIMETIBODY(TM) platform, that contains two EMP1 sequences as a pharmacophore…”
Get full text

CNTO 530: Molecular pharmacology in human UT-7 EPO cells and pharmacokinetics and pharmacodynamics in mice by Bugelski, P.J., Capocasale, R.J., Makropoulos, D., Marshall, D., Fisher, P.W., Lu, J., Achuthanandam, R., Spinka-Doms, T., Kwok, D., Graden, D., Volk, A., Nesspor, T., James, I.E., Huang, C.

“…CNTO 530 is a 58 kD antibody Fc domain fusion protein, created using Centocor's MIMETIBODY™ platform, that contains two EMP1 sequences as a pharmacophore. CNTO…”
Get full text

Pharmacokinetics and Pharmacodynamics of CNTO 528, a Novel Erythropoietin Receptor Agonist in Normal and Anemic Rats by Bugelski, Peter, Nesspor, T., Spinka-Doms, T., Makropoulos, D., Eirikis, E., Fisher, J., Volk, A., Shamberger, K., James, I., Fisher, P., Pool, C., Jang, H., Miller, B., Huang, C., Heavner, G., Knight, D., Ghrayeb, J., Scallon, B.

“…CNTO 528 is a member of a group of novel stimulants of erythropoiesis that has recently entered clinical trials. Although CNTO 528 bears no sequence homology…”
Get full text

The Fully Human Antibody CNTO1275 Effectively Inhibits Human IL-12 and IL-23 Mediated Th1 and Th17 Cell Function and Provides Clinical Benefit to Patients with Plaque Psoriasis by Benson, Jacqueline, Assistant Director, Centocor Research and Development, Discovery Research, Radnor, PA, Orlovsky, Yevgeniya, Senior Associate Scientist, Centocor Research and Development, Radnor, PA, Staquet, Kim, Manager, Centocor Research and Development, Radnor, PA, Luo, Jinquan, Principal Research Scientist, Centocor Research and Development, Radnor, PA, Branigan, Patrick, Research Scientist, Centocor Research and Development, Radnor, PA, Lamb, Roberta, Senior Associate Scientist, Centocor Research and Development, Radnor, PA, Li, Jian, Research Scientist, Centocor Research and Development, Radnor, PA, Capocasale, Renold, Research Scientist, Centocor, Radnor, PA, Huber, Janine, Senior Associate Scientist, Therakos, Exton, PA, Scallon, Bernie, Sr Research Fellow, Centocor, Radnor, PA, Peritt, David, Director, Therakos, Exton, PA, David Shealy, Senior Research Fellow, Centocor Research and Development, Radnor, PA, Heavner, George, Distinguished Research Fellow, Centocor Research and Development, Radnor, PA, Giles-Komar, Jill, Director, Centocor Research and Development, Radnor, PA, Nesspor, Tom, Senior Associate Scientist, Centocor, Radnor, PA

Get full text